BNT325

BNT325 · DualityBio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BNT325, covering 2025-02-27 to 2025-02-27. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]